BREAKTHROUGH T1D: Form 990, tax year 2017
View the entire original 990 at ProPublica ↗
- Organization
- BREAKTHROUGH T1D (EIN 23-1907729)
- Tax period
- 2017-07-01 to 2018-06-30
- Filed
- 2018-12-19
- IRS object ID
- 201803539349300815
- Schema version
- 2017v2.3
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-12-19T13:09:36-06:00 | ReturnTs |
| Tax Period End | 2018-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 345 PARK AVE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10154 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2017-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 231907729 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF INTERNATIONAL | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % GARY CURTO C/O JDRF INT | InCareOfNm |
| Business Name Control | JDRF | BusinessNameControlTxt |
| Phone | 2127859500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY 15TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JOANNE MARTZ | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Signature | 2018-12-19 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | NICOLE FITZMAURICE | PreparerPersonNm |
| PTIN | P01491005 | PTIN |
| Phone | 2127859700 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 38.126.140.251 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Federal Original Submission Id | 20543020183535000000 | FederalOriginalSubmissionId |
| Federal Original Submission Id | 2018-12-19 | FederalOriginalSubmissionIdDt |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | 77CC1D621559563551A28EC037FDBF081FD11258 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | EE4E115A3C9DFA99524036053EAAB45418171949 | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2017 | TaxYr |
| Build TS | 2019-02-21 02:37:17Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | DEREK RAPP | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY 14TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $260,616,536 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.jdrf.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1970 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | THE MISSION OF JDRF IS TO ACCELERATE BREAKTHROUGHS TO CURE, PREVENT AND TREAT TYPE I DIABETES. SEE SCHEDULE O | ActivityOrMissionDesc |
| Voting Members Governing Body | 34 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 33 | VotingMembersIndependentCnt |
| Total Employee | 886 | TotalEmployeeCnt |
| Total Volunteers | 249300 | TotalVolunteersCnt |
| Total Gross UBI | $17,064 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $39,647 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $199,896,852 | PYContributionsGrantsAmt |
| CY Contributions Grants | $219,968,105 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,227,269 | PYInvestmentIncomeAmt |
| CY Investment Income | $7,177,001 | CYInvestmentIncomeAmt |
| PY Other Revenue | $1,129,676 | PYOtherRevenueAmt |
| CY Other Revenue | $2,970,878 | CYOtherRevenueAmt |
| PY Total Revenue | $202,253,797 | PYTotalRevenueAmt |
| CY Total Revenue | $230,115,984 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $79,009,656 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $84,651,980 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $75,347,284 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $81,433,187 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $2,328 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $27,984,238 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $39,432,392 | PYOtherExpensesAmt |
| CY Other Expenses | $42,340,180 | CYOtherExpensesAmt |
| PY Total Expenses | $193,789,332 | PYTotalExpensesAmt |
| CY Total Expenses | $208,427,675 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $8,464,465 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $21,688,309 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $198,753,573 | TotalAssetsBOYAmt |
| Total Assets EOY | $226,353,181 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $121,385,069 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $129,947,696 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $77,368,504 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $96,405,485 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | At JDRF, we work tirelessly to accelerate breakthroughs to cure, prevent and treat type 1 diabetes (T1D). We continually expand our scientific knowledge, our connections and collaborations, our partners and global presence to unlock the science that will stop T1D. While we fight for a cure, we strive just as hard to develop therapies to help people right now. JDRF and our scientists are leading T1D research around the world. We address key gaps to move research faster and farther across the development pipeline and to translate breakthroughs into new therapies for people with T1D. This enables us to advance science with the most potential and to drive research that attracts more resources and scientific expertise to the field. We invest in the early stages, allowing researchers to pursue innovative ideas and approaches that will lead to breakthrough treatments. JDRF also works to drive new therapies and technologies to market so they get into the hands of people with T1D more quickly. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $84,651,980 | ExpenseAmt |
| Grant | $84,651,980 | GrantAmt |
| Desc | RESEARCH FUNDING - FOR THE FY18 PERIOD ENDING JUNE 30, 2018, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $85 MILLION IN RESEARCH GRANT NET EXPENSE WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $11.3 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS WHICH ARE RECORDED TO THE ORGANIZATION'S BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING. SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $23,138,667 | ExpenseAmt |
| Desc | RESEARCH SUPPORT - JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO RESEARCH SUPPORT. SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $56,283,982 | ExpenseAmt |
| Desc | PUBLIC EDUCATION AND OUTREACH - JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES AND OTHERS ABOUT T1D AND ITS COMPLICATIONS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH. SEE SCHEDULE O. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $164,074,629 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | Yes (true) | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (true) | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | Yes (true) | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 1044 | IRPDocumentCnt |
| IRP Document W2 G | 5 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 886 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | IS | ForeignCountryCd |
| Foreign Country | DA | ForeignCountryCd |
| Foreign Country | NL | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Form1098 C Filed | Yes (true) | Form1098CFiledInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 34 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 33 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | Yes (true) | LocalChaptersInd |
| Policies Reference Chapters | Yes (true) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | Yes (true) | InvestmentInJointVentureInd |
| Written Policy Or Procedure | Yes (true) | WrittenPolicyOrProcedureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ID | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TX | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WY | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | GARY CURTO CO JDRF INT | PersonNm |
| Phone | 2124797551 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY 1TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (44 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| MIKE LEE FY16-18 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LARRY SOLER FY16-18 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| WENDY WOOD FY16-18 | |||||||||
| CHAIR, INVESTMENT | 10.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| NANETTE DETURK FY17-19 | |||||||||
| CHAIR, ADVOCACY | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MICHELLE GRIFFIN FY17-19 | |||||||||
| CHAIR, DEVELOPMENT | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| STEPHEN NEWMAN MD FY17-19 | |||||||||
| CHAIR, RESEARCH | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| RANDY ANDERSON FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| TIMOTHY CLARK FY18-20 | |||||||||
| BOARD MEMBER | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MARK FISCHER-COLBRIE FY16-18 | |||||||||
| CHAIRMAN OF THE BOARD | 20.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| LISA REED FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MARVIN DAITCH FY16-18 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| PAM EDMONDS FY16-18 | |||||||||
| BOARD MEMBER | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JEFF PLUMER FY16-18 | |||||||||
| CHAIR, AUDIT | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LISA WALLACK FY16-18 | |||||||||
| SECRETARY, CHAIR NOMINATING | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| SEAN DOHERTY FY17-19 | |||||||||
| CHAIR, JDRF T1D FUND LLC | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| PAUL HEATH FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| KAREN JORDAN FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JOHN KAMPFE FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| ELLEN LEAKE FY17-19 | |||||||||
| BOARD VICE-CHAIR | 10.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| DOUG LOWENSTEIN FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DAYTON OGDEN FY17-19 | |||||||||
| CHAIR, TALENT & COMPENSATION | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| ANGIE PLATT FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JERRY WISLER FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| KAREY L WITTY FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| GRANT BEARD FY18-20 | |||||||||
| CHAIR, FINANCE | 10.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| BRANDON ARBITER FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| STEVEN DAVIS FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| CATHY BAIER FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MARY ELIZABETH BUNZEL FY18-19 | |||||||||
| CHAIT, CHANCELLORS | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JENNIFER BENNETT FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JOE LACHER FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| KIM ROOSEVELT FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| CHRISTOPHER TURNER FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MATT VAREY FY18-20 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DEREK RAPP | |||||||||
| PRESIDENT AND CEO | 50.0 | 0.0 | $850,000 | $0 | $47,460 | Yes (X) | |||
| SANDRA HIJIKATA | |||||||||
| CHIEF DEV OFFICER & ASST. SECY | 50.0 | 0.0 | $395,000 | $0 | $18,348 | Yes (X) | |||
| MARK GREENE | |||||||||
| CFO & ASST. TRES | 50.0 | 0.0 | $398,000 | $0 | $26,205 | Yes (X) | |||
| JILL CLARK | |||||||||
| CHIEF OF STAFF & ASST. SECY | 50.0 | 0.0 | $289,041 | $0 | $17,309 | Yes (X) | |||
| JONATHAN R BEHR | |||||||||
| MANAGING DIRECTOR JDRF-T1D FND | 50.0 | 0.0 | $372,500 | $0 | $34,761 | Yes (X) | |||
| AARON KOWALSKI | |||||||||
| CHIEF MISSION OFFICER | 50.0 | 0.0 | $418,091 | $0 | $42,152 | Yes (X) | |||
| STEVEN GRIFFEN MD | |||||||||
| SVP RESEARCH | 50.0 | 0.0 | $326,430 | $0 | $36,664 | Yes (X) | |||
| ALISA NORRIS | |||||||||
| CHIEF MARKETING OFFICER | 50.0 | 0.0 | $374,755 | $0 | $47,422 | Yes (X) | |||
| JULIA GREENSTEIN | |||||||||
| VP RESEARCH | 50.0 | 0.0 | $315,790 | $0 | $14,636 | Yes (X) | |||
| SUSAN YUN | |||||||||
| CHIEF PEOPLE OFFICER | 50.0 | 0.0 | $303,455 | $0 | $19,942 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $4,043,062 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $304,899 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 162 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| DDC ADVOCACY | |||||
| 805 15th Street NW | WASHINGTON | DC | 20005 | LEGISLATIVE CONSULT | $497,250 |
| 10UP LLC | |||||
| 2765 CARRADALE DR | ROSEVILLE | CA | 95661 | WEB DEVELOPMENT | $338,199 |
| CDS GLOBAL | |||||
| 1901 BELL AVE | DES MOINES | IA | 50315 | 3RD PARTY LOCK BOX | $583,780 |
| BLUE STATE DIGITAL | |||||
| 101 AVE OF THE AMERICAS | NEW YORK | NY | 10013 | DIGITAL CONSULTING | $479,119 |
| AKA ENTERPRISE SOLUTIONS | |||||
| 875 SIXTH AVE 20th FLOOR | NEW YORK | NY | 10001 | EPM IMPLEMENTATION | $710,885 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 51 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $4,294,747 | FederatedCampaignsAmt |
| Fundraising | $127,990,024 | FundraisingAmt |
| All Other Contributions | $87,683,334 | AllOtherContributionsAmt |
| Noncash Contributions | $20,144,817 | NoncashContributionsAmt |
| Total Contributions | $219,968,105 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,326,587 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $17,064 | UnrelatedBusinessRevenueAmt |
| Exclusion | $1,309,523 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $7,651,000 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,800,586 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $5,850,414 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,850,414 | TotalRevenueColumnAmt |
| Exclusion | $5,850,414 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $28,454,512 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $127,990,024 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $28,454,512 | FundraisingDirectExpensesAmt |
| Gaming Gross Income | $1,423,288 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $245,454 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,177,834 | TotalRevenueColumnAmt |
| Exclusion | $1,177,834 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | MISC PROGRAM REVENUE | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $1,793,044 | TotalRevenueColumnAmt |
| Exclusion | $1,793,044 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $1,793,044 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $230,115,984 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $17,064 | UnrelatedBusinessRevenueAmt |
| Exclusion | $10,130,815 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $61,518,639 | TotalAmt |
| Program Services | $61,518,639 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,133,341 | TotalAmt |
| Program Services | $23,133,341 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,481,235 | TotalAmt |
| Program Services | $1,488,741 | ProgramServicesAmt |
| Management And General | $347,373 | ManagementAndGeneralAmt |
| Fundraising | $645,121 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $60,427 | TotalAmt |
| Program Services | $36,256 | ProgramServicesAmt |
| Management And General | $8,460 | ManagementAndGeneralAmt |
| Fundraising | $15,711 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $62,676,897 | TotalAmt |
| Program Services | $42,318,201 | ProgramServicesAmt |
| Management And General | $7,220,843 | ManagementAndGeneralAmt |
| Fundraising | $13,137,853 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,983,990 | TotalAmt |
| Program Services | $1,347,990 | ProgramServicesAmt |
| Management And General | $277,759 | ManagementAndGeneralAmt |
| Fundraising | $358,241 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,458,573 | TotalAmt |
| Program Services | $2,671,984 | ProgramServicesAmt |
| Management And General | $624,200 | ManagementAndGeneralAmt |
| Fundraising | $1,162,389 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,772,065 | TotalAmt |
| Program Services | $5,860,926 | ProgramServicesAmt |
| Management And General | $1,368,089 | ManagementAndGeneralAmt |
| Fundraising | $2,543,050 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,014,034 | TotalAmt |
| Program Services | $1,325,412 | ProgramServicesAmt |
| Management And General | $591,831 | ManagementAndGeneralAmt |
| Fundraising | $1,096,791 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $679,672 | TotalAmt |
| Program Services | $407,803 | ProgramServicesAmt |
| Management And General | $95,154 | ManagementAndGeneralAmt |
| Fundraising | $176,715 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $189,821 | TotalAmt |
| Program Services | $113,893 | ProgramServicesAmt |
| Management And General | $26,575 | ManagementAndGeneralAmt |
| Fundraising | $49,353 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,211,012 | TotalAmt |
| Program Services | $1,211,012 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,328 | TotalAmt |
| Fundraising | $2,328 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $449,309 | TotalAmt |
| Management And General | $449,309 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,431,813 | TotalAmt |
| Program Services | $1,459,088 | ProgramServicesAmt |
| Management And General | $340,454 | ManagementAndGeneralAmt |
| Fundraising | $632,271 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,116,784 | TotalAmt |
| Program Services | $3,070,070 | ProgramServicesAmt |
| Management And General | $716,350 | ManagementAndGeneralAmt |
| Fundraising | $1,330,364 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,125,442 | TotalAmt |
| Program Services | $686,520 | ProgramServicesAmt |
| Management And General | $191,325 | ManagementAndGeneralAmt |
| Fundraising | $247,597 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,458,076 | TotalAmt |
| Program Services | $2,719,426 | ProgramServicesAmt |
| Management And General | $757,873 | ManagementAndGeneralAmt |
| Fundraising | $980,777 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,138,531 | TotalAmt |
| Program Services | $4,881,813 | ProgramServicesAmt |
| Management And General | $1,135,477 | ManagementAndGeneralAmt |
| Fundraising | $2,121,241 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,977,590 | TotalAmt |
| Program Services | $1,786,554 | ProgramServicesAmt |
| Management And General | $416,863 | ManagementAndGeneralAmt |
| Fundraising | $774,173 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,594,270 | TotalAmt |
| Program Services | $1,556,562 | ProgramServicesAmt |
| Management And General | $363,198 | ManagementAndGeneralAmt |
| Fundraising | $674,510 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,333,042 | TotalAmt |
| Program Services | $2,643,156 | ProgramServicesAmt |
| Management And General | $736,617 | ManagementAndGeneralAmt |
| Fundraising | $953,269 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $501,201 | TotalAmt |
| Program Services | $304,730 | ProgramServicesAmt |
| Management And General | $86,708 | ManagementAndGeneralAmt |
| Fundraising | $109,763 | FundraisingAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| OUTREACH EXPENSES | $2,586,429 | $1,646,521 | $355,375 | $584,533 |
| DUES & FEES | $1,424,567 | $906,879 | $195,736 | $321,952 |
| OTHER MISC EXPENSES | $1,108,587 | $979,112 | $63,239 | $66,236 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $208,427,675 | TotalAmt |
| Program Services | $164,074,629 | ProgramServicesAmt |
| Management And General | $16,368,808 | ManagementAndGeneralAmt |
| Fundraising | $27,984,238 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,026,999 | TotalAmt |
| Program Services | $719,323 | ProgramServicesAmt |
| Management And General | $111,224 | ManagementAndGeneralAmt |
| Fundraising | $1,196,451 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,695,495 | BOYAmt |
| EOY | $14,717,083 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $30,545,972 | BOYAmt |
| EOY | $56,336,253 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $28,143,186 | BOYAmt |
| EOY | $29,143,990 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,274,402 | BOYAmt |
| EOY | $21,529,716 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,000,000 | BOYAmt |
| EOY | $1,500,000 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,592,386 | BOYAmt |
| EOY | $5,991,334 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $25,831,752 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $18,502,543 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,719,880 | BOYAmt |
| EOY | $7,329,209 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,164,626 | BOYAmt |
| EOY | $47,882,217 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $39,867,626 | BOYAmt |
| EOY | $30,662,349 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,750,000 | BOYAmt |
| EOY | $11,261,030 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $198,753,573 | BOYAmt |
| EOY | $226,353,181 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,729,137 | BOYAmt |
| EOY | $22,350,808 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $94,060,180 | BOYAmt |
| EOY | $94,919,621 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,934,693 | BOYAmt |
| EOY | $10,051,979 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,661,059 | BOYAmt |
| EOY | $2,625,288 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $121,385,069 | BOYAmt |
| EOY | $129,947,696 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $39,586,000 | BOYAmt |
| EOY | $57,009,483 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $30,441,504 | BOYAmt |
| EOY | $31,828,002 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,341,000 | BOYAmt |
| EOY | $7,568,000 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $77,368,504 | BOYAmt |
| EOY | $96,405,485 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $198,753,573 | BOYAmt |
| EOY | $226,353,181 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $21,688,309 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$2,651,328 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $210,068,935 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $198,918,214 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $196,804,267 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $199,896,852 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $219,968,105 | CurrentTaxYearAmt |
| Total | $1,025,656,373 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $210,068,935 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $198,918,214 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $196,804,267 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $199,896,852 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $219,968,105 | CurrentTaxYearAmt |
| Total | $1,025,656,373 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $7,606,983 | SubstantialContributorsTotAmt |
| Public Support Total170 | $1,018,049,390 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,646,615 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $987,577 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $465,379 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $548,825 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,309,523 | CurrentTaxYearAmt |
| Total | $4,957,919 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $6,810 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $2,516 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $112,437 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $33,150 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $17,064 | CurrentTaxYearAmt |
| Total | $171,977 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $136,667 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $256,146 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $94,769 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $283,014 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,793,044 | CurrentTaxYearAmt |
| Total | $2,563,640 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $1,033,349,909 | TotalSupportAmt |
| Public Support CY170 | 0.98519 | PublicSupportCY170Pct |
| Public Support PY170 | 0.98793 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Form4720 Filed | false | Form4720FiledInd |
| Volunteers | Yes (true) | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | Yes (true) | MediaAdvertisementsInd |
| Media Advertisements | $807 | MediaAdvertisementsAmt |
| Mailings Members | Yes (true) | MailingsMembersInd |
| Mailings Members | $85,018 | MailingsMembersAmt |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | Yes (true) | GrantsOtherOrganizationsInd |
| Grants Other Organizations | $548 | GrantsOtherOrganizationsAmt |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $847,570 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | Yes (true) | RalliesDemonstrationsInd |
| Rallies Demonstrations | $505,331 | RalliesDemonstrationsAmt |
| Other Activities | false | OtherActivitiesInd |
| Total Lobbying Expenditures | $1,439,274 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | JDRF LOBBYING ACTIVITIES | FormAndLineReferenceDesc |
| Explanation | FORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization funding type 1 diabetes (T1D) research. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. Through research and advocacy, JDRF is accelerating progress on the most promising opportunities to cure, prevent and treat T1D and its complications. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance the discovery, development, and delivery of better therapies for T1D. JDRF has been instrumental in securing the renewal of the Special Diabetes Program, which provides $150MM annually for T1D research at the National Institutes of Health. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,341,367 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $268,304 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $42,070 | OtherExpendituresAmt |
| End Year Balance | $7,567,601 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,176,427 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $367,446 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $202,506 | OtherExpendituresAmt |
| End Year Balance | $7,341,367 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,141,514 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $37,913 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,000 | OtherExpendituresAmt |
| End Year Balance | $7,176,427 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,426,222 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $11,292 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $296,000 | OtherExpendituresAmt |
| End Year Balance | $7,141,514 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,837,461 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $625,761 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $37,000 | OtherExpendituresAmt |
| End Year Balance | $7,426,222 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prmnnt Endowment Balance EOY | 1.00000 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $4,786,090 | OtherCostOrOtherBasisAmt |
| Depreciation | $3,855,564 | DepreciationAmt |
| Book Value | $930,526 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $21,045,661 | OtherCostOrOtherBasisAmt |
| Depreciation | $14,646,979 | DepreciationAmt |
| Book Value | $6,398,682 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Land Buildings | OtherLandBuildingsGrp | |
| Total Book Value Land Buildings | $7,329,208 | TotalBookValueLandBuildingsAmt |
| Financial Derivatives | FinancialDerivativesGrp | |
| Closely Held Equity Interests | CloselyHeldEquityInterestsGrp |
Other Securities OtherSecuritiesGrp (2 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| HEDGE FUNDS | $19,209,614 | F |
| US-NON-PUBLIC INVESTMENT FUNDS | $11,452,735 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $30,662,349 | TotalBookValueSecuritiesAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | SPLIT INTEREST CHRT RMDR TRUST | Desc |
| Amt | $2,625,288 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $2,625,288 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $227,015,347 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$2,651,328 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | -$2,651,328 | RevenueNotReportedAmt |
| Revenue Subtotal | $229,666,675 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $449,309 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $449,309 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $230,115,984 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $207,978,366 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Subtotal | $207,978,366 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $449,309 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $449,309 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $208,427,675 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| ORGANIZATION'S ENDOWMENT FUNDS | FORM 990, PART X, LINE 28 & 29 & SCH D, PART V THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATIONS GENERAL EXEMPT PURPOSE. |
| INCOME TAX POSITION OF JDRF INT. | 990 SCH-D, PART X, LINE 2 JDRF IS A NOT FOR PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501 (C) (3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRF'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. INCOME TAX LIABILITIES ARE RECOGNIZED WHEN SUCH POSITIONS ARE QUANTIFIABLE AND LIKELY TO BE REALIZED. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2018 AND 2017. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | OfficesOfficesCnt | EmployeeEmployeeCnt |
|---|---|---|---|---|---|
| North America | Grantmaking | RESEARCH GRANTS | $3,662,429 | ||
| Middle East and North Africa | Grantmaking | RESEARCH GRANTS | $543,725 | ||
| East Asia and the Pacific | Grantmaking | RESEARCH GRANTS | $4,450,088 | ||
| Europe (Including Iceland and Greenland) | Grantmaking | RESEARCH GRANTS | $14,477,099 | ||
| Europe (Including Iceland and Greenland) | Program Services | RESEARCH SUPPORT | $302,393 | 2 | 2 |
| Central America and the Caribbean | Investments | Investments | $4,963,929 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 2 | SubtotalOfficesCnt |
| Subtotal Employees | 2 | SubtotalEmployeesCnt |
| Total Office | 2 | TotalOfficeCnt |
| Total Employee | 2 | TotalEmployeeCnt |
| Subtotal Spent | $28,399,663 | SubtotalSpentAmt |
| Total Spent | $28,399,663 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (64 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Description Of Non Cash AsstDescriptionOfNonCashAsstTxt | Valuation Method UsedValuationMethodUsedDesc |
|---|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $115,000 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | $249,243 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $125,165 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $930,622 | CHECK/WIRE | N/A | N/A | |
| Middle East and North Africa | $328,734 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $1,431,786 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $60,419 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $311,315 | CHECK/WIRE | N/A | N/A | |
| North America | IMMUNE THERAPIES | $297,112 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $64,728 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $200,000 | CHECK/WIRE | N/A | N/A | |
| North America | $395,332 | CHECK/WIRE | N/A | N/A | |
| North America | $1,194,079 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $110,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $172,535 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $183,460 | CHECK/WIRE | N/A | N/A | |
| North America | $529,939 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $60,816 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $248,600 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $603,376 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $120,000 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $249,561 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $124,403 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $250,000 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $247,317 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | $906,704 | CHECK/WIRE | N/A | N/A | |
| North America | $64,728 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $200,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $458,238 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $191,237 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $432,961 | CHECK/WIRE | N/A | N/A | |
| North America | $342,276 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | ARTIFICIAL PANCREAS | $250,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $233,283 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THEPAPIES | $58,779 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $112,355 | CHECK/WIRE | N/A | N/A | |
| Middle East and North Africa | IMMUNE THERAPIES | $109,991 | CHECK/WIRE | N/A | N/A |
| Middle East and North Africa | IMMUNE THERAPIES | $105,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $529,908 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $250,000 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $1,297,298 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | BETA CELL | $413,885 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $430,950 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $118,496 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $247,500 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $883,066 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $69,570 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $99,532 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL | $125,000 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $215,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $625,737 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $238,465 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $70,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $95,067 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $250,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $649,999 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $955,880 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $349,659 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $149,767 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $1,461,283 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $96,377 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $174,838 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $1,026,547 | CHECK/WIRE | N/A | N/A |
| North America | $250,000 | CHECK/WIRE | N/A | N/A |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 43 | Total501c3OrgCnt |
| Total Other Org | 21 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | Yes (true) | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | GRANT MONITORING PROCEDURES | FormAndLineReferenceDesc |
| Explanation | SCH-F PART I LINE 2 Research grants are awarded by JDRF's Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRF's goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | AUTOMATIVE RECOVERY SERV | PersonNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | TWO WESTBROOK CORORATE CENTER SUIT | AddressLine1Txt |
| City | WESTCHESTER | CityNm |
| State Abbreviation | IL | StateAbbreviationCd |
| ZIP | 60154 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activity | CAR DONATION | ActivityTxt |
| Fundraiser Control Of Funds | Yes (true) | FundraiserControlOfFundsInd |
| Gross Receipts | $261,400 | GrossReceiptsAmt |
| Retained By Contractor | $107,183 | RetainedByContractorAmt |
| Net To Organization | $154,217 | NetToOrganizationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $261,400 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $107,183 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $154,217 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AZ | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DE | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | ID | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | IN | LicensedStatesCd |
| Licensed States | IA | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | MT | LicensedStatesCd |
| Licensed States | NE | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | SD | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
| Licensed States | WY | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | ILLINOIS GALA | Event1Nm |
| Gross Receipts Event1 | $4,981,354 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $4,121,472 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $859,882 | GrossRevenueEvent1Amt |
| Non Cash Prizes Event1 | $13 | NonCashPrizesEvent1Amt |
| Rent Facility Costs Event1 | $70,748 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $333,740 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $332,072 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $123,309 | OtherDirectExpensesEvent1Amt |
| Event2 | ILLINOIS WALK | Event2Nm |
| Gross Receipts Event2 | $3,859,625 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $3,488,799 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $370,826 | GrossRevenueEvent2Amt |
| Non Cash Prizes Event2 | $13,604 | NonCashPrizesEvent2Amt |
| Food And Beverage Event2 | $8,829 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $8,356 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $260,800 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 364 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $147,603,557 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $120,379,753 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $27,223,804 | GrossRevenueOtherEventsAmt |
| Non Cash Prizes Other Events | $82,193 | NonCashPrizesOtherEventsAmt |
| Rent Fclty Costs Other Events | $3,765,120 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $2,732,904 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $3,286,150 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $17,436,674 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $156,444,536 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $127,990,024 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $28,454,512 | GrossRevenueTotalEventsAmt |
| Non Cash Prizes Total Events | $95,810 | NonCashPrizesTotalEventsAmt |
| Rent Fclty Costs Total Events | $3,835,868 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $3,075,473 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $3,626,578 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $17,820,783 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $28,454,512 | DirectExpenseSummaryEventsAmt |
Gaming Information GamingInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Revenue Other Gaming | $1,423,288 | GrossRevenueOtherGamingAmt |
| Cash Prizes Other Gaming | $20,000 | CashPrizesOtherGamingAmt |
| Non Cash Prizes Other Gaming | $225,454 | NonCashPrizesOtherGamingAmt |
| Volunteer Labor Other Gaming | false | VolunteerLaborOtherGamingInd |
| Gross Revenue Total Gaming | $1,423,288 | GrossRevenueTotalGamingAmt |
| Cash Prizes Total Gaming | $20,000 | CashPrizesTotalGamingAmt |
| Non Cash Prizes Total Gaming | $225,454 | NonCashPrizesTotalGamingAmt |
| Direct Expense Summary Gaming | $245,454 | DirectExpenseSummaryGamingAmt |
| Net Gaming Income Summary | $1,177,834 | NetGamingIncomeSummaryAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| States Where Gaming Conducted | AL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AK | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AZ | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AR | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CO | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | DE | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | DC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | FL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | GA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | HI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ID | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | KS | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | KY | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | LA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ME | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MD | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MS | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MO | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NE | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NV | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NH | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NJ | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NM | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NY | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ND | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OK | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OR | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | PW | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | PA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | RI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | SC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | SD | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | TN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | TX | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | UT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | VT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | VA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WV | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WY | StatesWhereGamingConductedCd |
| Licensed | Yes (true) | LicensedInd |
| License Suspended Etc | false | LicenseSuspendedEtcInd |
| Gaming With Nonmembers | false | GamingWithNonmembersInd |
| Member Of Other Entity | false | MemberOfOtherEntityInd |
| Gaming Other Facility | 1.00000 | GamingOtherFacilityPct |
| Individual With Books | GARY CURTO | IndividualWithBooksNm |
Persons With Books US Address PersonsWithBooksUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY-14TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct With3rd Prty For Game Rev | false | CntrctWith3rdPrtyForGameRevInd |
| Gaming Manager Person | GARY CURTO TAX MANAGER -JDRF | GamingManagerPersonNm |
| Gaming Manager Compensation | $0 | GamingManagerCompensationAmt |
| Gaming Manager Services Prov | FILING GAMING APPLICATIONS AND REPORTS | GamingManagerServicesProvTxt |
| Gaming Manager Is Employee | Yes (X) | GamingManagerIsEmployeeInd |
| Charitable Distribution Rqr | Yes (true) | CharitableDistributionRqrInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE G, PART I, LINE 2 | FormAndLineReferenceDesc |
| Explanation | INSURANCE AUTO AUCTIONS LLC IS A STATE LICENSED PROFESSIONAL FUNDRAISER THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CONTACT THE COMPANY DIRECTLY THROUGH A TOLL FREE NUMBER TO COORDINATE THE DONATION, FOLLOWING WHICH INSURANCE AUTO AUCTIONS HANDLES ALL REQUIRED IRS 1098C REPORTING. FOR THE PERIOD ENDING 6/30/18, THE CAR PROGRAM RAISED $261,400 WITH TOTAL EXPENSES OF $107,183 WITH THE NET PROCEEDS OF $154,217 PROVIDED DIRECTLY TO JDRF. JDRF PAYS NO ADDITIONAL EXPENSES OR FEES TO INSURANCE AUTO AUCTIONS FOR THIS PROGRAM. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (80 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|---|
| BENAROYA RESEARCH INST AT VIRGINIA MASON | |||||||||
| 1201 9TH AVE | SEATTLE | WA | 98101 | 910653422 | 501(C)3 | $2,098,652 | N/A | N/A | |
| ANN AND ROBERT LURIE CHILDREN'S HOSPITAL | |||||||||
| 225 EAST CHICAGO AVENUE | CHICAGO | IL | 60611 | 362170833 | 501(C)3 | $60,000 | N/A | N/A | IMMUNE THERAPIES |
| CAPILLARY BIOMEDICAL INC | |||||||||
| 56 HAVENWOOD | IRVINE | CA | 92617 | 464787731 | $201,500 | N/A | N/A | IMMUNE THERAPIES | |
| CASE WESTERN UNIVERSITY | |||||||||
| 10900 EUCLID AVE | CLEVELAND | OH | 44106 | 341018992 | 501(C)3 | $62,640 | N/A | N/A | IMMUNE THERAPIES |
| CORNELL UNIVERSITY | |||||||||
| 377 PINE TREE RD | ITHACA | NY | 14850 | 150532082 | 501(C)3 | $282,000 | N/A | N/A | IMMUNE THERAPIES |
| CAM MED LLC | |||||||||
| 29 EXETER STREET | WEST NEWTON | MA | 02465 | 999999999 | $100,000 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF ARIZONA | |||||||||
| PO BOX 210158 | TUCSON | AZ | 85004 | 113661893 | 501(C)3 | $797,276 | N/A | N/A | |
| CRITICAL PATH INSTITUTE | |||||||||
| 1730 EAST RIVER ROAD | TUCSON | AZ | 85718 | 201991334 | $151,000 | N/A | N/A | ||
| INDIANA UNIVERSITY | |||||||||
| 980 INDIANA AVENUE | INDIANAPOLIS | IN | 46202 | 356018940 | 501(C)3 | $937,267 | N/A | N/A | |
| BETH ISRAEL MEDICAL CENTER | |||||||||
| 330 BROOKLINE AVE | BOSTON | MA | 02215 | 135564934 | 501(C)3 | $570,000 | N/A | N/A | |
| JOSLIN DIABETES CENTER | |||||||||
| 1 JOSLIN PL | BOSTON | MA | 02215 | 042203836 | 501(C)3 | $2,117,298 | N/A | N/A | |
| FREQENCY THERAPEUTICS | |||||||||
| 300 TECHNOLOGY SQUARE | WOBURN | MA | 01801 | 999999999 | $35,000 | N/A | N/A | ||
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | |||||||||
| 77 MASSACHUSETTS AVE | CAMBRIDGE | MA | 02139 | 042103594 | 501(C)3 | $799,829 | N/A | N/A | |
| INDIANA BIOSCIENCES RES INST | |||||||||
| 1345 W 16TH STREET | INDIANAPOLIS | IN | 46202 | 462882271 | 501(C)3 | $150,000 | N/A | N/A | |
| CALIFORNIA INST FOR BIOMEDICAL RESEARCH | |||||||||
| 11119 NTORRY PINES RD | LAJOLLA | CA | 92037 | 956047739 | 501(C)3 | $2,292,400 | N/A | N/A | |
| EMORY UNIVERSITY | |||||||||
| 201 DOWMAN DRIVE | ATLANTA | GA | 30322 | 580566256 | 501(C)3 | $359,530 | N/A | N/A | |
| MAYO CLINIC | |||||||||
| 1216 2ND ST SW | ROCHESTER | MN | 55902 | 411405254 | 501(C)3 | $445,564 | N/A | N/A | IMMUNE THERAPIES |
| GEORGIA TECH RESEARCH CORP | |||||||||
| 505 TENTH STREET | ATLANTA | GA | 30332 | 580603146 | 501(C)3 | $167,674 | N/A | N/A | IMMUNE THERAPIES |
| STANFORD UNIVERSITY | |||||||||
| 291 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 501(C)3 | $730,809 | N/A | N/A | |
| JUST BIOTHERAPEUTICS | |||||||||
| 401 TERRY AVE N | SEATTLE | WA | 98109 | 999999999 | $1,000,000 | N/A | N/A | IMMUNE THERAPIES | |
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | |||||||||
| 550 FIRST AVENUE | NEW YORK | NY | 10016 | 135562309 | 501(C)3 | $100,000 | N/A | N/A | |
| HEALTH PARTNERS INSTITUTE | |||||||||
| PO BOX 1524 | MINNEAPOLIS | MN | 55440 | 999999999 | 501(C)3 | $373,016 | N/A | N/A | |
| RTI INTERNATIONAL | |||||||||
| RES TRIANGLE PK | RES TRIANGLE | NC | 27709 | 440680117 | 501(C)3 | $411,375 | N/A | N/A | |
| NEW YORK STEM CELL FOUNDATION | |||||||||
| 619 WEST 54TH STREET | NEW YORK | NY | 10019 | 202905531 | 501(C)3 | $200,000 | N/A | N/A | |
| BECKMAN RESEARCH INST OF THE CITY OF HOPE | |||||||||
| 1500 EAST DUARTE ROAD | DUARTE | CA | 91010 | 953432210 | 501(C)3 | $1,824,293 | N/A | N/A | |
| OREGON HEALTH & SCIENCE UNIVERSITY | |||||||||
| 3181 SW SAM JACKSON | PORTLAND | OR | 97239 | 237083114 | 501(C)3 | $500,871 | N/A | N/A | IMMUNE THERAPIES |
| IBM | |||||||||
| 1 N CASTLE DR | ARMONK | NY | 10504 | 999999999 | $1,360,000 | N/A | N/A | IMMUNE THERAPIES | |
| PACIFIC DIABETES TECHNOLOGIES | |||||||||
| 12154 SW GARDEN PLACE | PORTLAND | OR | 97223 | 999999999 | 501(C)3 | $220,689 | N/A | N/A | |
| UNIVERSITY OF FLORIDA | |||||||||
| 1600 SW ARCHER ROAD | GAINESVILLE | FL | 32610 | 590974739 | 501(C)3 | $12,209,832 | N/A | N/A | |
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | |||||||||
| 55 LAKE AVE NORTH | WORCESTER | MA | 01605 | 043167352 | 501(C)3 | $62,640 | N/A | N/A | |
| UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | |||||||||
| 1450 NW 10TH AVE | MIAMI | FL | 33136 | 590624458 | 501(C)3 | $1,770,121 | N/A | N/A | |
| UNIVERSITY OF VIRGINIA | |||||||||
| 104 MIDMONT LN | CHARLOTTESVILLE | VA | 22902 | 416042488 | 501(C)3 | $212,516 | N/A | N/A | |
| UNIVERSITY OF MICHIGAN | |||||||||
| 2003 S STATE STREET | ANN ARBOR | MI | 48109 | 386006309 | 501(C)3 | $625,000 | N/A | N/A | |
| LEK CONSULTING | |||||||||
| 75 STATE STREET | BOSTON | MA | 02109 | 999999999 | $396,250 | N/A | N/A | IMMUNE THERAPIES | |
| LOCKHEED MARTIN | |||||||||
| 199 BORTON LANDING RD | MOORESTOWN | NJ | 08057 | 999999999 | $261,908 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF CALIFORNIA | |||||||||
| 3333 CA ST | SAN FRANCISCO | CA | 94122 | 956006143 | 501(C)3 | $2,738,857 | N/A | N/A | |
| UNIVERSITY OF WISCONSIN-MADISON | |||||||||
| 1220 LINDEN DRIVE | MADISON | WI | 53706 | 396006492 | 501(C)3 | $500,000 | N/A | N/A | |
| UT SOUTHWESTERN MEDICAL CENTER | |||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 756002868 | 501(C)3 | $2,045,720 | N/A | N/A | |
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||
| 1211 MEDICAL CENTER DR | NASHVILLE | TN | 37232 | 620476822 | 501(C)3 | $278,547 | N/A | N/A | |
| LOUISIANA STATE UNIV HEALTH SCIENCE | |||||||||
| 433 BOLIVAR STREET | NEW ORLEANS | LA | 70112 | 270158443 | 501(C)3 | $899,171 | N/A | N/A | IMMUNE THERAPIES |
| BAYLOR COLLEGE OF MEDICINE-RESEARCH INSTITUTE | |||||||||
| ONE BAYLOR PLAZA | HOUSTON | TX | 77030 | 751921898 | 501(C)3 | $180,000 | N/A | N/A | |
| BROAD INSTITUTE | |||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | 263428781 | 501(C)3 | $253,781 | N/A | N/A | |
| NAT INST OF DIABETS & DIGESTIVE DISEASES | |||||||||
| 6707 DEMOCRACY BLVD | BETHESDA | MD | 20892 | 999999999 | $200,000 | N/A | N/A | ||
| UNIVERSITY OF CONNECTICUT | |||||||||
| 69 N EAGLEVILLE | STORRS | CT | 06269 | 066085975 | 501(C)3 | $249,998 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF SOUTH FLORIDA | |||||||||
| 4202 E FOWLER AVE | TAMPA | FL | 33620 | 590879015 | 501(C)3 | $426,420 | N/A | N/A | IMMUNE THERAPIES |
| JAEB CENTER FOR HEALTH RESEARCH FND | |||||||||
| 15310 Amberly Drive | TAMPA | FL | 33647 | 593187624 | 501(C)3 | $3,692,067 | N/A | N/A | |
| VIACYTE INC | |||||||||
| 3550 GENERAL ATOMICS | SAN DIEGO | CA | 92121 | 330884172 | $2,150,000 | N/A | N/A | ||
| COLUMBIA UNIVERSITY | |||||||||
| 535 W 116TH ST | NEW YORK | NY | 10027 | 135598093 | 501(C)3 | $110,000 | N/A | N/A | |
| YALE UNIVERSITY | |||||||||
| PO BOX 209010 | NEW HAVEN | CT | 06520 | 060646973 | 501(C)3 | $2,113,953 | N/A | N/A | IMMUNE THERAPIES |
| SFC FLUIDICS INC | |||||||||
| 534 WEST RES CENTER | FAYETTEVILLE | AR | 72701 | 999999999 | $200,000 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | |||||||||
| 1720 2ND AVS S | BIRMINGHAM | AL | 35294 | 636001138 | 501(C)3 | $175,622 | N/A | N/A | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 55 FRUIT STREET | BOSTON | MA | 02114 | 042697983 | 501(C)3 | $486,646 | N/A | N/A | |
| NORTHWESTERN UNIVERSITY | |||||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 231352685 | 501(C)3 | $910,280 | N/A | N/A | |
| ICAHN SCHOOL OF MEDICINE MOUNT SINAI | |||||||||
| 1 GUSTAVE L LEVY PLACE | NEW YORK | NY | 10029 | 136171197 | 501(C)3 | $438,716 | N/A | N/A | |
| NOVARTIS INSTITUTE-GENOMICS | |||||||||
| 10675 JOHN HOPKINS DR | SAN DIEGO | CA | 92121 | 223610512 | $2,000,000 | N/A | N/A | ||
| ILLINOIS INSTITUTE OF TECHNOLOGY | |||||||||
| 3300 SOUTH FEDERAL STREET | CHICAGO | IL | 60616 | 362170136 | 501(C)3 | $250,000 | N/A | N/A | |
| UNIVERSITY OF MINNESOTA | |||||||||
| 200 OAK ST SE | MINNEAPOLIS | MN | 55455 | 416007513 | 501(C)3 | $299,999 | N/A | N/A | |
| JACKSON LABORATORY | |||||||||
| 600 MAIN STREET | BAR HARBOR | ME | 04609 | 010211513 | 501(C)3 | $312,227 | N/A | N/A | |
| RUTGERS THE STATE UNIVERSITY | |||||||||
| 175 UNIVERSITY AVE | NEWARK | NJ | 07107 | 462354111 | 501(C)3 | $439,559 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF WASHINGTON | |||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 911486484 | 501(C)3 | $161,617 | N/A | N/A | |
| WESTERN MICHIGAN UNIVERSITY | |||||||||
| 300 PORTAGE STREET | KALAMAZOO | MI | 49007 | 454135256 | 501(C)3 | $125,477 | N/A | N/A | |
| THE MEDICAL COLLEGE OF WISCONSIN | |||||||||
| 8701 W WATERTOWN | MILWAUKEE | WI | 53226 | 611730890 | 501(C)3 | $324,765 | N/A | N/A | IMMUNE THERAPIES |
| TIDEPOOL | |||||||||
| 555 BRYANT | ST PALO ALTO | CA | 94301 | 462302287 | $664,109 | N/A | N/A | ARTIFICIAL PANCREAS | |
| THE METHODIST HOSPITAL RESEARCH INST | |||||||||
| 6670 BERTNER AVE | HOUSTON | TX | 77030 | 999999999 | 501(C)3 | $109,821 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF UTAH | |||||||||
| 201 PRESIDENTS CR | SALT LAKE CITY | UT | 84112 | 876000525 | 501(C)3 | $730,746 | N/A | N/A | GLUCOSE MODULATION |
| WAYNE STATE UNIVERSITY | |||||||||
| 42 W WARREN AVE | DETROIT | MI | 48202 | 383555142 | 501(C)3 | $385,822 | N/A | N/A | ENCAPSULATED ISLETS |
| PROTOMER TECHNOLOGIES | |||||||||
| 530 SOUTH LAKE AVE | PASADENA | CA | 91101 | 474206994 | $270,000 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||||
| 3720 S FLOWER STREET | LOS ANGELES | CA | 90089 | 951642394 | 501(C)3 | $166,022 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF COLORADO | |||||||||
| 1800 GRANT STREET | DENVER | CO | 80203 | 846049811 | 501(C)3 | $4,144,193 | N/A | N/A | IMMUNE THERAPIES |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | |||||||||
| 1 COLLEGE HALL | PHILADELPHIA | PA | 19104 | 231352685 | 501(C)3 | $110,000 | N/A | N/A | IMMUNE THERAPIES |
| UNITIO INC | |||||||||
| 11 AVENUE DE LAYFETTE | BOSTON | MA | 02111 | 451623549 | $1,250,000 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF MARYLAND BALTIMORE | |||||||||
| 620 WEST LEXINGTON ST | BALTIMORE | MD | 21201 | 522004514 | 501(C)3 | $273,718 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF TEXAS HEALTH SCIENCE | |||||||||
| 7703 FLOYD CURL DRIVE | SAN ANTONIO | TX | 78229 | 741586031 | 501(C)3 | $890,776 | N/A | N/A | IMMUNE THERAPIES |
| WASHINGTON UNIVERSITY | |||||||||
| One Brookings Drive | St Louis | MO | 63130 | 430653611 | 501(C)3 | $303,340 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH | |||||||||
| 2385 IRVING HILL DR | LAWRENCE | KS | 66045 | 480680117 | 501(C)3 | $249,997 | N/A | N/A | IMMUNE THERAPIES |
| VTV THERAPEUTICS LLC | |||||||||
| 4170 MENDENHALL OAKS | HIGH POINT | NC | 27265 | 999999999 | $540,000 | N/A | N/A | IMMUNE THERAPIES | |
| BOSTON CHILDREN'S HOSPITAL | |||||||||
| 300 LONGWOOD AVENUE | BOSTON | MA | 02115 | 043266103 | 501(C)3 | $572,597 | N/A | N/A | IMMUNE THERAPIES |
| HARVARD COLLEGE | |||||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 042103580 | 501(C)3 | $617,165 | N/A | N/A | IMMUNE THERAPIES |
| WILLIAM MARSH RICE UNIVERSITY | |||||||||
| 6100 MAIN STREET M16 | HOUSTON | TX | 77005 | 741109620 | 501(C)3 | $150,000 | N/A | N/A | IMMUNE THERAPIES |
| DREXEL UNIVERSITY | |||||||||
| 2900 W QUEEN LANE | PHILADELPHIA | PA | 19104 | 231352630 | 501(C)3 | $150,000 | N/A | N/A | IMMUNE THERAPIES |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 63 | Total501c3OrgCnt |
| Total Other Org | 16 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | GRANT MONITORING PROCEDURES | FormAndLineReferenceDesc |
| Explanation | SCH-I PART I LINE 2 Research grants are awarded by JDRF's Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRF's goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | false | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt |
|---|---|---|---|---|---|---|
| DEREK RAPP | ||||||
| PRESIDENT AND CEO | $600,000 | $150,000 | $100,000 | $12,337 | $35,123 | $897,460 |
| AARON KOWALSKI | ||||||
| CHIEF MISSION OFFICER | $381,551 | $36,540 | $7,912 | $34,240 | $460,243 | |
| SANDRA HIJIKATA | ||||||
| CHIEF DEV OFFICER & ASST. SECY | $375,000 | $20,000 | $12,337 | $6,011 | $413,348 | |
| MARK GREENE | ||||||
| CFO & ASST. TRES | $366,250 | $31,750 | $12,337 | $13,868 | $424,205 | |
| JILL CLARK | ||||||
| CHIEF OF STAFF & ASST. SECY | $264,833 | $24,208 | $10,828 | $6,481 | $306,350 | |
| STEVEN GRIFFEN MD | ||||||
| SVP RESEARCH | $115,830 | $20,000 | $190,600 | $12,337 | $24,327 | $363,094 |
| JONATHAN R BEHR | ||||||
| MANAGING DIRECTOR JDRF-T1D FND | $302,500 | $70,000 | $12,337 | $22,424 | $407,261 | |
| ALISA NORRIS | ||||||
| CHIEF MARKETING OFFICER | $353,333 | $21,422 | $12,337 | $35,085 | $422,177 | |
| JULIA GREENSTEIN | ||||||
| VP RESEARCH | $290,323 | $25,467 | $12,337 | $2,299 | $330,426 | |
| SUSAN YUN | ||||||
| CHIEF PEOPLE OFFICER | $278,334 | $25,121 | $12,337 | $7,605 | $323,397 | |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| HOUSING ALLOWANCE | SCHEDULE J PART I, LINE 1A Derek Rapp, Pres & CEO, received a housing allowance as per the terms of his employment agreement. For the 2017 calendar year, the housing allowance provided to Derek Rapp was $75,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B) (III). |
| OTHER REPORTABLE COMPENSATION | SCHEDULE J PART II, C (B)(iii) DEREK RAPP RECEIVED TRAVEL & ALLOWANCE EXPENSES FOR THE 2017 CALENDAR YEAR, THE ALLOWANCE PROVIDED TO MR. RAPP WAS $25,000; SUCH AMOUNT WAS TREATED AS TAXABLE COMPENSATION AND INCLUDED IN HIS FORM W-2. THIS AMOUNT WAS ALSO REPORTED ON SCHEDULE J, PART II, COL (B)(iii). |
| NON-FIXED PAYMENTS | FORM 990, SCHEDULE J, PART I, LINE 7 JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II). |
| SEVERANCE PAYMENTS | SCHEDULE J, PART I, LINE 4A DR.STEVEN GRIFFEN RECEIVED A SEVERANCE PAYMENT OF $190,600 WHICH IS REPORTED ON SCHEDULE J, PART II, COL. (B)(III) OTHER REPORTABLE COMPENSATION. |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp
Name Of Interested NameOfInterested
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | ELIZABETH KECKLER | PersonNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship Description | DAUGHTER OF ELLEN LEAKE | RelationshipDescriptionTxt |
| Transaction | $60,427 | TransactionAmt |
| Transaction | EMPLOYMENT AT JDRF INT. | TransactionDesc |
| Sharing Of Revenues | false | SharingOfRevenuesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | BUSINESS TRANSACTION | FormAndLineReferenceDesc |
| Explanation | SCHEDULE L, PART IV, COLUMN B ELLEN LEAKE WAS THE BOARD VICE-CHAIR FOR YEAR END 6/30/2018 SCHEDULE L, PART IV, COLUMN C FOR EMPLOYEES LISTED, TOTAL COMPENSATION INCLUDES EMPLOYER PAID BENEFITS | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp |
Cars And Other Vehicles CarsAndOtherVehiclesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 7 | ContributionCnt |
| Noncash Contributions Rpt F990 | $225,454 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | TICKET SALES | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 444 | ContributionCnt |
| Noncash Contributions Rpt F990 | $7,241,869 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | NET PROCEEDS OF SALE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | MISC AUCTION ITEMS DONATED | Desc |
| Contribution | 27906 | ContributionCnt |
| Noncash Contributions Rpt F990 | $12,677,494 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FAIR MARKET VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 3 | Form8283ReceivedCnt |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (true) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| THIRD PARTY ASSISTANCE | LINE 32B INSURANCE AUTO AUCTIONS LLC IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, INSURANCE AUTO AUCTIONS HANDLES ALL IRS 1098-C REPORTING. INSURANCE AUTO AUCTIONS IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/18, THE CAR PROGRAM LLC RAISED $261,400 WITH TOTAL EXPENSES OF $107,183. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY INSURANCE AUTO AUCTIONS ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-18 WAS $154,217. |
| NONCASH CONTRIBUTIONS | FORM 990, SCHEDULE M, PAGE 1 TYPES OF PROPERTY AND THE AMOUNTS LISTED IN PART I LINES 6, 9, and 25 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES, SECURITIES, AND MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS & RAFFLES. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990- PART I, LINE 7B | INCLUDES 512(A)(7) AMOUNTS THAT ARE NOT REVENUE AND, THEREFORE, NOT REPORTED AS SUCH ON FORM 990. |
| PUBLIC DOCUMENTS | FORM 990, PAGE 6, PART VI, SECTION C, LINE 19 The organization makes its governing documents, conflict of interest policy and financial statements available to the public on its website: www.JDRF.org. The public may access copies of JDRF's W-9, annual reports, 990 tax returns, 501(c)(3) IRS letter, and audited financials, at the following link: www.jdrf.org/about/financials |
| EXECUTIVE COMPENSATION POLICY | PART VI, SECTION B, LINES 15a & 15b JDRF's Board of Directors charges a Talent and Compensation Committee to develop and recommend a compensation philosophy that applies to all employees of JDRF, including recommendations regarding the compensation and benefits of JDRF senior management for approval by the Executive Committee. The Committee works in collaboration with the President and CEO and the Chief People Officer and other senior staff personnel in the JDRF Human Resources Department to ensure that 1) the Foundation's talent strategy supports and is aligned with its overall organization strategies; 2) JDRF is in compliance with IRS guidelines for determining reasonableness in pay practices; and 3) overall compensation for JDRF's key executives is competitive and aligned with pay philosophy. To attract and retain top scientific and executive talent to advance its mission, the organization pays competitive and appropriate salaries as determined by analysis of reliable data and input from independent third-party consultants. The review of JDRF executive compensation and benefits under the procedures noted above is completed annually by an independent Compensation Committee, and the basis for their determination IS documented contemporaneously in the minutes of the Committee's meetings, including most recently on June 20, 2018. |
| FORM 990 REVIEW PROCESS | SECTION B, PART VI, QUESTION 11B JDRF has a rigorous standard approach to reviewing its 990. The Organization's Tax Manager works with its outside tax professionals to prepare the return and all supporting schedules. The draft return is reviewed by a number of individuals, including JDRF's Chief Financial Officer and Director of Accounting and Finance, the Chief Executive Officer, other executives, its external senior tax advisor and others as necessary to ensure accuracy. Any questions and changes with respect to the draft return are addressed. Following this process, the return is reviewed by JDRF's Audit Committee of the Board of Directors with its outside tax advisors. Once approved, the return is distributed to all members of JDRF's Board of Directors for review and comment before it is filed with the Internal Revenue Service. |
| FORM 990 PART VI, LINE 2 | BOARD MEMBERS DOUG LOWENSTEIN & LARRY SOLER HAVE A BUSINESS RELATIONSHIP. |
| PART III: STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS | LINE 4A ($84,651,980) RESEARCH GRANTS JDRF has played a significant role in nearly every T1D therapeutic advance of the past four decades. We have more than 500 active T1D research grants funded in the United States and 19 other countries around the world - more than 150 grants in 2018 alone. Additionally, seventy-five JDRF-funded clinical trials are currently under way. The full impact of JDRF's research investment extends well beyond direct funding. JDRF leverages partnerships with academia, industry and clinicians to accelerate the most promising research opportunities. Accomplished experts and leaders in the field of T1D science and medicine guide the organization's funding efforts in the United States and around the world. Our highest priority is developing a cure for T1D and its complications. As we increase our understanding of the causes of T1D, we will also uncover ways to prevent them from occurring. At the same time, we're focused on developing better therapies to help people with T1D live healthier lives today. The foundation's diversified research portfolio includes the following therapy areas: Artificial Pancreas: Artificial pancreas (AP) systems use technology to replicate the operation of a normal human pancreas and are one of the most revolutionary advances in diabetes care since the discovery of insulin. JDRF has been pivotal in developing and pursuing AP systems, and has transformed the field in less than 10 years by working closely with numerous partners, researchers and companies to overcome the challenges that had prevented AP technology from moving forward. Today, JDRF's Artificial Pancreas Program is working to advance next-generation technology that is small, user-friendly and accurate, so that people with T1D can get through the day without needing to check blood sugar levels or dose insulin as often. These systems link continuous glucose monitors and insulin pumps to smart software so that the right amount of insulin is delivered at the right time. Our advocacy efforts, for instance, helped shave years off the regulatory approval process for the first Artificial Pancreas system, now on the market. Beta Cell Regeneration: The JDRF Beta Cell Regeneration Program aims to find and develop treatments to maintain the health and function of insulin-producing beta cells - and to develop therapies to generate new ones. The creation of the Network for Pancreatic Organ Donors with Diabetes, or nPOD, a JDRF initiative, helped uncover the opportunities of beta cell regeneration. Beta Cell Replacement: The JDRF Beta Cell Replacement program focuses on creating and then placing new insulin-producing beta cells back in the body, potentially allowing people with T1D to live years, even decades, without glucose monitoring and insulin injections. Complications: Despite advances in glucose control, many people with T1D are still at risk of developing serious kidney, eye, heart and nerve diseases. JDRF's Complications Program focuses on eye and kidney diseases, two areas where we believe we will have the most impact. Glucose Control: Even with today's technology, maintaining tight glucose control can be challenging. Our Glucose Control Program is driving clinical trials and breakthrough solutions to make the management of glucose easier and to keep people with T1D healthier. Immunotherapies: In people with T1D, the immune system mistakes the body's own cells for dangerous invaders and targets the pancreas' insulin-producing beta cells. As a result of beta cell death, people with T1D depend on external insulin to survive. Our approach through JDRF's Immunotherapies Program is to disable overactive immune assassins, boost "good" cells that can control and inhibit the killer cells, and restore immune control. Prevention: The JDRF Prevention Program works to eliminate the threat of T1D from future generations - and translate research knowledge into therapies that can stop T1D from developing. Until we have found ways to prevent T1D, we must stop or slow its progression during its earliest stages. Our approach is to expand T1D screening, delay the onset of T1D, and develop a vaccine. For more information on these scientific initiatives, visit jdrf.org/research. The JDRF T1D Fund (www.t1dfund.org), a wholly owned subsidiary of JDRF, is a venture philanthropy fund accelerating life-changing solutions to treat, prevent and cure T1D through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines to help people living with T1D or at risk of developing the disease. The T1D Fund invests in opportunities that drive our mission, with an exclusive focus on the best commercial opportunities. All funds go directly to support companies developing approaches to treat, prevent and cure T1D. In accordance with GAAP, $11.3MM of the T1D Fund's total investments as of June 30, 2018 are reflected in the Balance Sheet (Part X) and not included within the organization's research-related mission expense. LINE 4B ($23,138,667) RESEARCH SUPPORT JDRF's in-house team of skilled and credentialed scientific, policy and government relations professionals play critical roles in leading and supporting the research strategy and distribution of research funds from JDRF - and our partner organizations - to create a world without T1D. Our professionals identify, evaluate and influence groundbreaking research funded by JDRF, other foundations, governments and industry to accelerate the mission we all share. JDRF professionals work with regulatory and policy officials to ensure research can proceed without delay and that research results are well understood by healthcare decision makers. As part of these efforts, JDRF organizes and funds scientific meetings, symposia, and conferences to review research proposals, ensure that JDRF's research strategy is aligned with the needs of the T1D community, and allow JDRF to provide scientific updates on the research it manages. This effort ensures that all the research is continually shared and built upon by T1D researchers around the globe. JDRF's external Research Advisory Committee (RAC) is composed of professionals who are internationally renowned for their expertise in research as well as the care and treatment of people with T1D. The RAC advises on matters of policy related to research philosophy and procedures. JDRF's work to bring together the best minds in the field enhances JDRF's ability to forecast future scientific direction, judge the potential effectiveness of new pathways, and identify gaps where JDRF funding can make the most impact. LINE 4C ($56,284,982) PUBLIC EDUCATION JDRF is uniquely qualified to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people living with T1D, their families and the general public, but also those at risk for developing the disease. T1D strikes both children and adults suddenly, and the adjustment period following a diagnosis can be overwhelming. That's why we support families navigating this challenging time. JDRF also educates people about the warning signs of T1D, which can be profoundly helpful in ensuring timely diagnoses and reducing the potential catastrophic consequences of undiagnosed T1D. JDRF also provides information and updates about current research directions and progress and about human clinical trials that are seeking participants (including through JDRF's Clinical Trials Connection matching tool: www.jdrf.org/research/clinical-trials). Through all of our 70 U.S. chapters, six international affiliates in Australia, Canada, Denmark, Israel, the Netherlands and United Kingdom - and our 30,000 members of our social network, TypeOneNation - JDRF supports the T1D community's diverse needs, connecting people with local support, expert resources, and the global effort to create a world without T1D. |
| CONFLICT OF INTEREST POLICY | FORM 990- PART VI-SECT B, LINE 12C All officers, directors, key employees, board and committee members (both chapters and international boards) are required to sign a conflict of interest policy annually and disclose any conflicts. The Office of the President and CEO manages this process, and JDRF's internal audit department annually audits to ensure compliance. If any conflict does arise, the board members with the conflicts will recuse themselves from the meeting and/or vote. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF T1D FUND LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | C/O JDRF - 26 BROADWAY 14TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 274967989 | EIN |
| Primary Activities | FUNDR/INVEST | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Total Income | $15,400,127 | TotalIncomeAmt |
| End Of Year Assets | $45,466,963 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF | BusinessNameLine1Txt |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CHARITABLE REMAINDER TRUST (5) | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | ANNUITY | PrimaryActivitiesTxt |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Controlled Organization | Yes (true) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE R, PART I, LINE (1B) | FormAndLineReferenceDesc |
| Explanation | THE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS. | ExplanationTxt |
Comments